This content is machine translated CKD: counteracting kidney progression and reducing the risk of CVD Targeted intervention through a multifactorial approach The Swiss Society of Nephrology (SGN) advocates targeted screening for defined risk groups. However, given the prevalence of chronic kidney disease (CKD) in primary care, it is hardly possible to...…
View Post 3 min This content is machine translated SGLT2 inhibitors and glucocorticoids Protective effect on kidney function is maintained SGLT2 inhibitors have been shown in randomized trials to be effective in improving cardiovascular and renal outcomes. However, the populations in these studies were carefully selected, usually excluding patients under...…
View Post 5 min This content is machine translated Type 2 diabetes Pharmacotherapy can lead to remission Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which,...…
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 5 min This content is machine translated SGLT2 inhibitors and GLP1-RA Are old, white men favored? Despite consistent recommendations and growing clinical evidence, uptake of SGLT2i and GLP1 RA therapies in people with type 2 diabetes and cardiorenal comorbidities has been slow. There is also relatively...…
View Post 5 min This content is machine translated Uncontrolled type 2 diabetes Empagliflozin as an effective addition to triple therapies In patients with type 2 diabetes (T2D), a balanced glucose concentration is mainly achieved through drug therapies. If blood glucose control remains poor despite a triple combination of oral hypoglycaemic...…
View Post 12 min This content is machine translated Diabetic ketoacidosis Recommendations for action in practice Diabetic ketoacidosis (DKA) is an acutely life-threatening complication of diabetes mellitus that occurs predominantly in type 1 diabetes, but is also increasingly occurring in people with type 2 diabetes. A… CME-Test
View Post 5 min This content is machine translated Journal Club Nephrolithiasis and gout: SGLT2i could be an effective supplement Nephrolithiasis and gout are diseases with an increasing global burden and often co-occur with type 2 diabetes mellitus. SGLT2 inhibitors, which were first approved for the treatment of hyperglycemia in…
View Post 4 min This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 5 min This content is machine translated Diabetic neuropathy and retinopathy How risky are SGLT2i and GLP1-RA? Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) play an important role in diabetes therapy. However, their effect on diabetic neuropathy and retinopathy is not clear.…
